AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...
Most of the biggest projects given the green light by the Chancellor are in already prosperous areas across the South of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback